SNS Research
Menu
Introducing SNS Market Intelligence Portal
Picture
The SNS Market Intelligence Platform integrates structured market forecasts with clinical development pipeline data in a single, interactive environment. This enables life sciences organizations to evaluate commercial opportunity, assess competitive risk, and align clinical and market strategy with greater precision across development and launch timelines.

Healthcare & Pharma Reports
SNS MArket Intelligence
Drug Development Pipelines

For Enquiries, Demo & Trial Requests please contact: [email protected]

Featured Research

Picture
The Psoriasis Drugs Market: 2025 – 2035: Opportunities, Challenges, Strategies & Forecasts​

Release Date: December 2025 
Number of Pages: 215 Tables and Figures: 63
Companies Profiles: 66 Pipeline Candidates: 51


The “Psoriasis Drugs Market: 2025 – 2035 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of the psoriasis drugs ecosystem including psoriasis disorders, types of treatment options, delivery technologies, key trends, market drivers, challenges, investment potential, leading therapies, drug development pipeline, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents market size forecasts for psoriasis drugs from 2025 through to 2035. The forecasts are further segmented by 4 therapeutic classes, 3 routes of administration, 4 distribution channels, 5 regions and 26 leading countries.

​The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report, and 2025 clinical drug development pipeline dataset profiling 51 future candidates.


For Enquiries, Sample Pages and Table of Contents Please Contact: [email protected]

Trending Research Reports

Skin Cancer Drugs Market: 2025
Dermatological Drugs Market: 2025
Digital Health: 2024
The Cancer Drugs Market: 2023-2033
Pre-Filled Syringes Market: 2023 - 2033
The mHealth (Mobile Healthcare) Ecosystem 2022
The Generic Drugs Market
The Glaucoma Drugs Market
The Ophthalmic Drugs Market

    ​Subscribe to our Newsletter

Submit

​​Client Testimonial

The SNS report covering “The Dermatological Drugs Market” is an invaluable one stop resource for plethora of information regarding the dermatological market. This report provides comprehensive view to both the business aspect as well as to the clinical one of the Derma market. It constitutes both an introduction to the various indications targeted at all that may want to enter into this vastly growing market, as well as to the commercial aspect of it, offering an encompassing analysis of the main players, the economics. Moreover, with its 15 years vision, it provides thoughtful projections into the future.
Nadav Schreibom, CEO, Sirbal LTD.

Search Website


Notable Customers


Media Coverage
Valeant Pharmaceuticals refers forecasts from our Glaucoma Drugs Report (Page 7)

Outlook Therapeutics features our Biosimilars Report in their IPO document (Page77-79)
​
Drug Development references findings from our Prefilled Syringes Market Report (Page 31)

Optometery Today by Association of Optometrists refers to our Ophthalmic Drugs Market Report

Air Cargo Eye refers to our Dermatological Drugs Market Report

​
Clarkson Consulting refers to our mHealth Forecasts in the Life Sciences Trends Report


Outsiders Club refers to our Generic Drugs research
Press Releases
SNS Research launches SNS Market Intelligence Platform now allowing secure digital dashboard access comprehensive pharmaceutical market data, pipeline analysis, and regional insights.

SNS Research Publishes Comprehensive 2025–2035 Global Dermatological Drugs Market Report​

Psoriasis Drugs Market to Reach 20 Billion Dollars in 2025 as SNS Research Releases Comprehensive 2025–2035 Industry Outlook

The global dermatological drug market is poised for substantial growth, driven by an increasing prevalence of skin disorders worldwide and a surge in the development of innovative therapies, according to a new report by SNS Research.


SNS Research reveals the digital health market will surpass $243 billion by 2024, as innovations in wearables, AI, and telehealth empower patients and revolutionize care delivery.

Our Research & Services

​Pharma Research Library
​Clinical Pipeline Datasets
Request Clinical Pipeline Data
Send an Inquiry
Purchase Report

Company

Home
​Our Customers
Press Releases
​​About Us 
​Media Coverage

More

Subscribe for Latest Updates
​Privacy Policy
​Disclosures
​
​​               Contact Us: [email protected] ​ ​                                     © 2026 SNS Research  ​
  • Home
  • Privacy Policy
  • Our Customers
  • Media Coverage
  • Press Releases
    • SNS Market Intelligence Platform PR
  • About Us
  • Contact Us
  • Pharma Reports
    • Drug Development Pipelines
  • Dermatological Drugs Market
  • Psoriasis Drugs Market
    • Psoriasis Drugs Pipeline
  • Digital Health Market
  • Skin Cancer Drugs Market 2025
  • Home
  • Privacy Policy
  • Our Customers
  • Media Coverage
  • Press Releases
    • SNS Market Intelligence Platform PR
  • About Us
  • Contact Us
  • Pharma Reports
    • Drug Development Pipelines
  • Dermatological Drugs Market
  • Psoriasis Drugs Market
    • Psoriasis Drugs Pipeline
  • Digital Health Market
  • Skin Cancer Drugs Market 2025